Nephros (NEPH) EBIAT (2016 - 2025)
Nephros (NEPH) has 16 years of EBIAT data on record, last reported at $337000.0 in Q3 2025.
- For Q3 2025, EBIAT rose 84.15% year-over-year to $337000.0; the TTM value through Sep 2025 reached $1.5 million, up 259.42%, while the annual FY2024 figure was $74000.0, 104.7% up from the prior year.
- EBIAT reached $337000.0 in Q3 2025 per NEPH's latest filing, up from $237000.0 in the prior quarter.
- Across five years, EBIAT topped out at $558000.0 in Q1 2025 and bottomed at -$2.8 million in Q4 2022.
- Average EBIAT over 5 years is -$539947.4, with a median of -$306000.0 recorded in 2023.
- Peak YoY movement for EBIAT: crashed 1350.91% in 2022, then soared 430.18% in 2025.
- A 5-year view of EBIAT shows it stood at $220000.0 in 2021, then plummeted by 1350.91% to -$2.8 million in 2022, then surged by 76.24% to -$654000.0 in 2023, then soared by 153.36% to $349000.0 in 2024, then fell by 3.44% to $337000.0 in 2025.
- Per Business Quant database, its latest 3 readings for EBIAT were $337000.0 in Q3 2025, $237000.0 in Q2 2025, and $558000.0 in Q1 2025.